Infigratinib in Subjects with Gastric or gastroesophageal junction Cancer with FGFR2 Amplification or Other Solid Tumors with Other FGFR Genetic Alterations(LB1001-201 study) Clinical information
| Title | Infigratinib in Subjects with Gastric or gastroesophageal junction Cancer with FGFR2 Amplification or Other Solid Tumors with Other FGFR Genetic Alterations(LB1001-201 study) Clinical information |
|---|---|
| Description | summary clinical data and data list |
| Organism | Homo sapiens |
| Data Type | Other Type of Clinical information |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA017207 |
| Release Date | 2023-10-24 |
| Submitter | lin shen (linshenpku@163.com) |
| Organization | Beijing Cancer Hospital |
| Submission Date | 2023-05-24 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
|---|---|---|---|---|---|---|---|
| OMIX004138-02 | summary clinical data and data list | 2 | Other Type of Clinical information | 2.4 MB | zip | 0 | Controlled |